Several studies from our group (Maguire et al., 2008; Meijer et al., 2009) and others (Denbo et al., 2011; Streck et al., 2006) have demonstrated the potential of IFN‐β gene therapy for glioblastoma. This evidence concerns the gene IFNB1 and glioblastoma.